Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
leucine rich repeat, Ig-like and transmembrane domains 1 | 0.641 | 0.615 | 4.6E-15 |
|
group | 0.070 | None | 1.000 | 7 | 0 | 2017 | 2019 | ||||||||
|
leucine rich repeat, Ig-like and transmembrane domains 1 | 0.641 | 0.615 | 4.6E-15 |
|
group | 0.070 | None | 1.000 | 7 | 0 | 2017 | 2019 | ||||||||
|
leucine rich repeat, Ig-like and transmembrane domains 1 | 0.641 | 0.615 | 4.6E-15 |
|
disease | 0.040 | None | 1.000 | 4 | 0 | 2017 | 2018 | ||||||||
|
leucine rich repeat, Ig-like and transmembrane domains 1 | 0.641 | 0.615 | 4.6E-15 |
|
phenotype | 0.040 | None | 1.000 | 4 | 0 | 2018 | 2020 | ||||||||
|
leucine rich repeat, Ig-like and transmembrane domains 1 | 0.641 | 0.615 | 4.6E-15 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 2017 | 2018 | ||||||||
|
leucine rich repeat, Ig-like and transmembrane domains 1 | 0.641 | 0.615 | 4.6E-15 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1995 | 2017 | ||||||||
|
leucine rich repeat, Ig-like and transmembrane domains 1 | 0.641 | 0.615 | 4.6E-15 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
leucine rich repeat, Ig-like and transmembrane domains 1 | 0.641 | 0.615 | 4.6E-15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
leucine rich repeat, Ig-like and transmembrane domains 1 | 0.641 | 0.615 | 4.6E-15 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
leucine rich repeat, Ig-like and transmembrane domains 1 | 0.641 | 0.615 | 4.6E-15 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
leucine rich repeat, Ig-like and transmembrane domains 1 | 0.641 | 0.615 | 4.6E-15 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
leucine rich repeat, Ig-like and transmembrane domains 1 | 0.641 | 0.615 | 4.6E-15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | ||||||||
|
leucine rich repeat, Ig-like and transmembrane domains 1 | 0.641 | 0.615 | 4.6E-15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1985 | 1985 | ||||||||
|
leucine rich repeat, Ig-like and transmembrane domains 1 | 0.641 | 0.615 | 4.6E-15 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1985 | 1985 | ||||||||
|
leucine rich repeat, Ig-like and transmembrane domains 1 | 0.641 | 0.615 | 4.6E-15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
leucine rich repeat, Ig-like and transmembrane domains 1 | 0.641 | 0.615 | 4.6E-15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | ||||||||
|
leucine rich repeat, Ig-like and transmembrane domains 1 | 0.641 | 0.615 | 4.6E-15 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
leucine rich repeat, Ig-like and transmembrane domains 1 | 0.641 | 0.615 | 4.6E-15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2020 | 2020 | ||||||||
|
leucine rich repeat, Ig-like and transmembrane domains 1 | 0.641 | 0.615 | 4.6E-15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
leucine rich repeat, Ig-like and transmembrane domains 1 | 0.641 | 0.615 | 4.6E-15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
leucine rich repeat, Ig-like and transmembrane domains 1 | 0.641 | 0.615 | 4.6E-15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
leucine rich repeat, Ig-like and transmembrane domains 1 | 0.641 | 0.615 | 4.6E-15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
leucine rich repeat, Ig-like and transmembrane domains 1 | 0.641 | 0.615 | 4.6E-15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
leucine rich repeat, Ig-like and transmembrane domains 1 | 0.641 | 0.615 | 4.6E-15 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
leucine rich repeat, Ig-like and transmembrane domains 1 | 0.641 | 0.615 | 4.6E-15 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 |